Armenia granted its first marketing authorization for Agenus’s BOT+BAL therapy in adults with previously treated MSS metastatic colorectal cancer without active liver metastases. The approval expands Agenus’s oncology footprint; rollout and access details were not disclosed.
published
Armenia granted its first marketing authorization for Agenus’s BOT+BAL therapy in adults with previously treated MSS metastatic colorectal cancer without active liver metastases. The approval expands Agenus’s oncology footprint; rollout and access details were
Latest documented BWB result
$AAPL market result
I sold the $AAPL $320 Puts for 11/20 - $5.30
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.